| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/23/2011 | EP2287299A1 Gene that imparts oxygen resistance and application thereof |
| 02/23/2011 | EP2287298A1 Lipolytic enzyme variants |
| 02/23/2011 | EP2287297A1 Lipolytic enzyme variants |
| 02/23/2011 | EP2287294A1 Novel process |
| 02/23/2011 | EP2287293A2 Thermophillic Bacterial Strains for the Production of Ethanol |
| 02/23/2011 | EP2287292A2 Plant derived hydroxy phenyl pyruvate dioxygneases (HPPD) resistant against triketone herbicides and transgenic plants containing these dioxygenases |
| 02/23/2011 | EP2287290A2 Nestin-expressing hair follicle stem cells |
| 02/23/2011 | EP2287287A1 Coryneform bacterium transformant having improved d-xylose-utilizing function |
| 02/23/2011 | EP2287285A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/23/2011 | EP2287199A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2287198A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2287196A2 Antibodies against thymic stromal lymphopoietin receptor for treating allergic diseases |
| 02/23/2011 | EP2287193A1 Antibody molecules having specificity for human IL-1 beta |
| 02/23/2011 | EP2287191A2 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 02/23/2011 | EP2287190A2 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 02/23/2011 | EP2287186A1 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| 02/23/2011 | EP2287185A2 High affinity TCR proteins and methods |
| 02/23/2011 | EP2287182A2 Differential in tumour gene products and use of same |
| 02/23/2011 | EP2287181A2 Differential in tumour gene products and use of same |
| 02/23/2011 | EP2287180A1 Poa p 5-derivatives with reduced allergenicity and T-cell reactivity |
| 02/23/2011 | EP2287177A2 Streptococcus agalactiae antigens I + II |
| 02/23/2011 | EP2287174A1 Enhanced purification of antibody fragments by apatite chromotography |
| 02/23/2011 | EP2286843A2 Compounds for targeting endothelial cells |
| 02/23/2011 | EP2286841A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 02/23/2011 | EP2286834A2 Use of skin penetration enhancers and barrier disruption agents to enhance transcutaneous immune response |
| 02/23/2011 | EP2285989A2 Novel targets for regulation of angiogenesis |
| 02/23/2011 | EP2285986A1 Adfp modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 02/23/2011 | EP2285974A2 Gene synthesis by convergent assembly of oligonucleotide subsets |
| 02/23/2011 | EP2285970A2 Compositions and methods for enhancing cellular transport of biomolecules |
| 02/23/2011 | EP2285969A1 Process, vectors and engineered cell lines for enhanced large-scale transfection |
| 02/23/2011 | EP2285968A1 Chimeric compositions and methods for regulating plant gene expression |
| 02/23/2011 | EP2285967A1 Fatty acid dehydratases and uses thereof |
| 02/23/2011 | EP2285966A1 Multi-species polynucleotide control sequences |
| 02/23/2011 | EP2285965A1 A design for rapidly cloning one or more polypeptide chains into an expression system |
| 02/23/2011 | EP2285964A1 Phage lambda display constructs |
| 02/23/2011 | EP2285963A2 Transcriptional and post-transcription regulation of transcription factor for drought resistance |
| 02/23/2011 | EP2285962A2 Novel therapeutic agents against hepatitis |
| 02/23/2011 | EP2285961A1 Oligonucleotides for treating inflammation and neoplastic cell proliferation |
| 02/23/2011 | EP2285960A2 Compositions and methods related to mirna modulation of neovascularization or angiogenesis |
| 02/23/2011 | EP2285959A2 Compositions comprising cmyc sirna and methods of use thereof |
| 02/23/2011 | EP2285958A1 Method of synthesizing polynucleotide variants |
| 02/23/2011 | EP2285957A1 Lysis, binding and/or wash reagent for isolating and/or purifying nucleic acids |
| 02/23/2011 | EP2285956A1 Method of directing the evolution of an organism |
| 02/23/2011 | EP2285952A2 Novel fusion proteins and use thereof for preparing hepatitis c vaccines |
| 02/23/2011 | EP2285853A2 Micellic assemblies |
| 02/23/2011 | EP2285832A2 Antibodies and processes for preparing the same |
| 02/23/2011 | EP2285826A1 Anti-angiogenic compositions and therapeutic applications thereof |
| 02/23/2011 | EP2285816A2 Method for isolating nucleic acids |
| 02/23/2011 | EP2285815A2 Method for isolating short-chain nucleic acids |
| 02/23/2011 | EP2285404A1 Yeast strain for the production of proteins with terminal alpha-1,3-linked galactose |
| 02/23/2011 | EP2285385A2 siRNA COMPOUNDS FOR INHIBITING NRF2 |
| 02/23/2011 | EP1986490B1 Model for muscular dystrophy and cardiomyopathy |
| 02/23/2011 | EP1960427B1 Multimeric fc receptor polypeptides |
| 02/23/2011 | EP1801209B1 Modified human hepatitis c virus genomic rna having autonomous replicative competence |
| 02/23/2011 | EP1794297B1 Subtilases |
| 02/23/2011 | EP1766411B1 Method for determining a tissue degradation process by detection of comp neoepitopes |
| 02/23/2011 | EP1724344B1 Process for producing amino acid |
| 02/23/2011 | EP1652934B1 Improved method of amplifying atp and use thereof |
| 02/23/2011 | EP1626985B1 Generation of artificial binding proteins based on ubiquitin proteins |
| 02/23/2011 | EP1576154B1 In vivo affinity maturation scheme |
| 02/23/2011 | EP1523497B1 Hsp70 from arthrobacter |
| 02/23/2011 | EP1499720B1 Gene targeting using replicating dna molecules |
| 02/23/2011 | EP1135504B1 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 02/23/2011 | EP1090108B1 Novel methods for rescue of rna viruses |
| 02/23/2011 | EP0972024B1 A tumor suppressor designated ts10q23.3 |
| 02/23/2011 | CN1934252B Thrombin derivatives and medicinal composition containing the same |
| 02/23/2011 | CN1902312B Method of constructing transgenic dendritic cell |
| 02/23/2011 | CN1655802B Bioadhesive directed somatic cell therapy |
| 02/23/2011 | CN101981452A Method for detection of pneumococcus |
| 02/23/2011 | CN101981205A Reagent comprising primer for detection of mRNA for cytokeratin-7 |
| 02/23/2011 | CN101981196A Methods and materials for the reproducible generation of high producer cell lines for recombinant proteins |
| 02/23/2011 | CN101981195A Plants having increased yield-related traits and a method for making the same |
| 02/23/2011 | CN101981194A Lipid metabolism proteins, combinations of lipid metabolism proteins and uses thereof |
| 02/23/2011 | CN101981193A Method for amplifying locus in bacterial cell |
| 02/23/2011 | CN101981192A Plants having increased tolerance to heat stress |
| 02/23/2011 | CN101981191A Nucleotide sequences and corresponding polypeptides conferring modulated growth rate and biomass in plants grown in saline and oxidative conditions |
| 02/23/2011 | CN101981190A Toxin of the spider phoneutria nigriventer for treatment of erectile dysfunction |
| 02/23/2011 | CN101981189A Methods and compositions capable of causing post-transcriptional silencing of gene expression in a synergic manner |
| 02/23/2011 | CN101981188A Selection of RNA-aptamers as anti-malaria agents |
| 02/23/2011 | CN101981187A Partial peptide of Survivin presented on MHC class II molecule and use thereof |
| 02/23/2011 | CN101981186A Novel DNA capable of being amplified by PCR with high selectivity and high efficiency |
| 02/23/2011 | CN101981185A Double-stranded lipid-modified RNA having high RNA interference effect |
| 02/23/2011 | CN101981184A High expression zymomonas promoters |
| 02/23/2011 | CN101981183A Method of gene transfer into cells using electrospray and apparatus therefor |
| 02/23/2011 | CN101981181A Method for preparation of platelet from IPS cell |
| 02/23/2011 | CN101981055A Anti-CD79B antibodies and immunoconjugates and methods of use |
| 02/23/2011 | CN101981053A Pegylated Abeta FAB |
| 02/23/2011 | CN101981051A Transcriptional activators involved in abiotic stress tolerance |
| 02/23/2011 | CN101980712A Targeting microRNAs for the treatment of liver cancer |
| 02/23/2011 | CN101980595A Delta4 desaturase and its use in making polyunsaturated fatty acids |
| 02/23/2011 | CN101980017A Anti-TNF antibodies, compositions, methods and uses |
| 02/23/2011 | CN101979661A Primer group and kit for multiple PCR detection of rabbit Pasteurella multocida and rabbit Bordetella bronchiseptica and detection method thereof |
| 02/23/2011 | CN101979658A Amplification refractory method for detecting single nucleotide polymorphism of multi drug resistance gene 1(MDR1) by introducing mutation to position-3 of primers |
| 02/23/2011 | CN101979650A Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 02/23/2011 | CN101979644A Method for preparing N-acetylneuraminic acid by one-step catalysis of fusion protein |
| 02/23/2011 | CN101979608A Corn transgenic technique of ion beam assisted pulse electrophoresis |
| 02/23/2011 | CN101979607A Method for preparing foot-and-mouth disease virus-resistant RNAi transgenic livestock |
| 02/23/2011 | CN101979606A Human reverse transcription foamy virus vector generated by adenovirus expression system |
| 02/23/2011 | CN101979605A Reporter gene labeled-mouse model for monitoring function of HBV specific CTLs in vivo and construction method and application thereof |
| 02/23/2011 | CN101979604A Herbicide resistant plant expression vector for wild eggplant salt tolerant gene StBADH |